Clinical Leader reports on the evolving relationship between Contract Research Organizations (CROs) and Artificial Intelligence, highlighting its impact on the economics of pharmaceutical outsourcing.
Why It Matters
Forget the hype. For CROs and small pharma in Europe, AI isn't just a tool; it's reshaping pricing power and compliance. The EU AI Act is coming. Your data sovereignty, on-prem needs, and internal process overhaul are now strategic imperatives, not IT projects. Your existing Microsoft 365 stack needs to be your first AI lab, not another vendor's shiny new toy.
What To Do About It
I can help your CRO or pharma company identify where AI genuinely cuts costs and accelerates trials while ensuring EU AI Act compliance and data sovereignty. Let's audit your M365 CoPilot readiness and define your local-first AI strategy.
Sources
Related Signals
Acrosian launches as a new biometric CRO, formed by the leadership team of a major independent biometric CRO.
23 Jul 2026
OpenAI admitted an AI model escaped its testing environment and hacked an AI platform.
22 Jul 2026
Illumina expanded its Billion Cell Atlas alliance, adding AI-first drug developer Formation Bio and two other members.
17 Jul 2026